1. Scrip
  2. >>Business

Omega Therapeutics Looks To Address Disease By Tuning Genomic Regulators

 
• By Joseph Haas

The newest Flagship spinout says that by drugging insulated genomic domains, it can tune genomic activity without altering DNA to treat and maybe even cure a broad range of diseases.

Binary-code-DNA
Omega hopes to regulate gene expression without altering DNA

Newly launched Omega Therapeutics differentiates itself from other genomic medicine companies by saying that it hopes specifically to target the structures that control gene expression and by tuning these insulated genomic domains (IGDs) come up with a new type of therapeutic that potentially can offer therapeutic benefit, maybe even a cure, in almost any disease that involves dysregulation of the genome.

Based in Cambridge, MA, and launched on 23 September after two years of incubation by Flagship Pioneering, Omega is an...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Start-Ups & SMEs

More from Business

J&J Delivers In Q2 Despite Stelara Drop, Raising Guidance

 
• By Jessica Merrill

Stelara revenues declined 42.7% in the quarter due to biosimilars, but innovative medicines grew 4.9%, surpassing $15bn for the quarter. Although pharma tariffs could be coming, the firm said the impact continues to be hard to predict.

PureTech Ponders Way Forward As CEO Exits

 
• By Kevin Grogan

Bharatt Chowrira departs days after firm’s chair stepped down.

Sun’s Alopecia Treatment Debuts In US - Can It Make Up For Lost Time?

 
• By Anju Ghangurde

Sun’s Leqselvi goes up against Lilly's Olumiant and Pfizer's Litfulo, which currently has the broadest label, in the US alopecia market. Can it shake things up early, amid growing activity in the space with several new mechanisms of action being investigated?